L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma. - Wikidata - awgldk - TriplyDB

L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma.

L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma.

http://www.wikidata.org/entity/Q33829964

about

Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review L1CAM in human cancer.Breast and lung metastasis from pancreatic neuroendocrine carcinoma L1 Cell Adhesion Molecule-Specific Chimeric Antigen Receptor-Redirected Human T Cells Exhibit Specific and Efficient Antitumor Activity against Human Ovarian Cancer in Mice L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma.L1CAM in the Early Enteric and Urogenital System.L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors.Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.L1 (CD171) is highly expressed in gastrointestinal stromal tumors.L1 cell adhesion molecule as a predictor for recurrence in pulmonary carcinoids and large-cell neuroendocrine tumors.Expression of L1CAM, COX-2, EGFR, c-KIT and Her2/neu in anaplastic pancreatic cancer: putative therapeutic targets?

P2860

Q26768483-C785C288-A790-407C-A996-CEA4D12F8DFA Q34482366-CD7824A6-AE59-46A4-8238-7332C5C4963E Q34538678-2B0D23E3-3024-48BA-BFF9-C8F98D393697 Q35892897-E827856A-ED31-49CD-BF4C-010E92356AD8 Q37716565-E5EEE651-F668-4A0C-A91C-35B443329614 Q39062702-54A3552B-4F6E-4552-A27F-BC7AD56F9666 Q40167054-89DD8D9D-C0CD-4923-8D04-918178B986F7 Q40211697-C085BE95-77AB-42C8-90F1-317949B0A176 Q40359512-E422BB10-131F-4CC4-8E05-0D018AA52E25 Q51802280-4989B56F-A6D6-46C1-970A-CFF1E21E35EB Q54675200-92CDD43E-1591-4F22-945E-68DB090AEA05

P2860

L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma.

http://www.wikidata.org/entity/Q33829964

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma.

@ast

L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma.

@en

type

label

L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma.

@ast

L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma.

@en

prefLabel

L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma.

@ast

L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma.

@en

P1433

Q33829964-289479DC-0232-4E82-A1B3-9FC3A15F3BEF

P1476

Q33829964-D35F16C4-7329-43FC-821B-F7C97DC590A0

P2093

Q33829964-02AF67FA-834F-4AE1-AB60-B2E495F985C5

Q33829964-53533A5A-63AB-4AD7-AB39-DE19E7495938

Q33829964-55DE99D4-CADB-4EE8-B68B-9F9295909433

Q33829964-68B1D089-2035-41C6-BB30-08AB42A162F6

Q33829964-8FCA3326-EA21-4DA9-9382-CC53154B7F1E

Q33829964-9CA1782A-838D-4AE0-8BC5-01D5D7607A83

Q33829964-AD7460F0-DFDB-4C3B-802E-FB60536A18A8

Q33829964-B9AAE3DC-CD16-4493-89CC-D6B92D95C709

Q33829964-F33456B3-F090-4972-A707-01D547AAE2E9

P2860

Q33829964-05F02E05-00F5-4CD6-BD47-F9A8AA75CD12

Q33829964-10FC70BE-4273-4CE0-85DF-49D4A376EDFA

Q33829964-46C9D82C-CE02-4C82-95B1-5D6994326F3F

Q33829964-4F932E53-02EC-4919-BDDD-33F3DFCB272B

Q33829964-510B5B9D-41EE-4614-9B16-4429736016AE

Q33829964-5CF868F6-B932-4EDA-BC3C-9F51A6B2AEDE

Q33829964-5E3F2444-B3BF-4522-AE91-FAB7C27D1B20

Q33829964-62CF4F68-7B47-49E7-8E66-EA68F7DE02E0

Q33829964-693C15EF-A58F-49B0-A634-F0B11EA2187E

Q33829964-71880C4C-6C51-4020-AE11-74EAE4D173BB

P304

Q33829964-493CE601-7B8F-4241-8F0C-A64FB2EA2020

P31

Q33829964-6F11D92B-1A5E-4008-8E5F-328A172D37E7

P356

Q33829964-83BB4426-F3C5-4EF2-9E4F-F04854A16FB9

P407

Q33829964-1E0CDD88-0DC3-4047-8C7A-23876BD2F3DD

P433

Q33829964-5B53C2EA-0D0E-47D5-B424-6EA683C8A563

P478

Q33829964-4DE3C781-B9D4-42E6-BD39-33F86101A8C9

P50

Q33829964-EB3F83A9-FE56-49D0-8444-D717B4C35499

P577

Q33829964-68B3EBEC-EB8F-4F76-8A84-B5B83514EDD7

P698

Q33829964-7A1C0E51-9704-42A4-94D1-276E5176EF33

P932

Q33829964-A63326DA-A1B3-4472-BA00-896485D56709

P356

P1433

World Journal of Gastroenterology

P1476

L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma.

@en

P2093

Emre F Yekebas

http://www.w3.org/2001/XMLSchema#string

Henning C Fiegel

http://www.w3.org/2001/XMLSchema#string

Jakob R Izbicki

http://www.w3.org/2001/XMLSchema#string

Jussuf T Kaifi

http://www.w3.org/2001/XMLSchema#string

Paulus G Schurr

http://www.w3.org/2001/XMLSchema#string

Robin Wachowiak

http://www.w3.org/2001/XMLSchema#string

Susann Petri

http://www.w3.org/2001/XMLSchema#string

Ulrich Zinnkann

http://www.w3.org/2001/XMLSchema#string

Uta Reichelt

http://www.w3.org/2001/XMLSchema#string

P2860

Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3

Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.

The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.

Critical determinants of metastasis.

Endocrine tumors of the gut and pancreas tumor biology and classification.

Ankyrin binding mediates L1CAM interactions with static components of the cytoskeleton and inhibits retrograde movement of L1CAM on the cell surface.

Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins.

Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors.

L1CAM, INP10, P-cadherin, tPA and ITGB4 over-expression in malignant pleural mesotheliomas revealed by combined use of cDNA and tissue microarray.

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.

P304

94-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V12.I1.94

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Melitta Schachner

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16440424

http://www.w3.org/2001/XMLSchema#string

P932

4077503

http://www.w3.org/2001/XMLSchema#string